Inventor
SMITH ERIC
US187 patents
⚠️ This page may combine multiple inventors who share the name “SMITH ERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
20 patentsUS9657102B2May 23, 2017
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
REGENERON PHARMA125 citations99
US8043617B2Oct 25, 2011
Human antibodies to human IL-6 receptor
REGENERON PHARMA91 citations99
US7582298B2Sep 1, 2009
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA390 citations99
US10772972B2Sep 15, 2020
Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
REGENERON PHARMA44 citations97
US10738130B2Aug 11, 2020
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
REGENERON PHARMA50 citations97
US9359437B2Jun 7, 2016
Antibodies comprising chimeric constant domains
REGENERON PHARMA91 citations97
US7534868B1May 19, 2009
Human antibodies to human delta like ligand 4
REGENERON PHARMA38 citations96
US7488806B2Feb 10, 2009
Human antibodies to human delta like ligand 4
REGENERON PHARMA41 citations96
US10179819B2Jan 15, 2019
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
REGENERON PHARMA25 citations93
US11384153B2Jul 12, 2022
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
REGENERON PHARMA16 citations92
US9884916B2Feb 6, 2018
High affinity antibodies to human IL-6 receptor
REGENERON PHARMA13 citations92
US7919593B2Apr 5, 2011
Human antibodies to human delta like ligand 4
REGENERON PHARMA25 citations92
US8048418B2Nov 1, 2011
Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
REGENERON PHARMA34 citations90
US11518807B2Dec 6, 2022
Heavy chain constant regions with reduced binding to Fc gamma receptors
REGENERON PHARMA8 citations86
US10556952B2Feb 11, 2020
Heavy chain constant regions with reduced binding to Fc gamma receptors
REGENERON PHARMA12 citations86
US11155633B2Oct 26, 2021
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
REGENERON PHARMA9 citations85
US10988537B2Apr 27, 2021
Antibodies comprising chimeric constant domains
REGENERON PHARMA10 citations85
US11725034B2Aug 15, 2023
IL2 agonists and methods of use thereof
REGENERON PHARMA4 citations84
US11548947B2Jan 10, 2023
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
REGENERON PHARMA10 citations84
US11453721B2Sep 27, 2022
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
REGENERON PHARMA10 citations84
WESTINGHOUSE AIR BRAKE CO
4 patentsUS5738416AApr 14, 1998
Railway braking apparatus to effect a change in a handbrake
WESTINGHOUSE AIR BRAKE CO47 citations95
US5701974ADec 30, 1997
Railway hand brake apparatus with visual condition indicator
WESTINGHOUSE AIR BRAKE CO59 citations95
US5586812ADec 24, 1996
Railway braking apparatus
WESTINGHOUSE AIR BRAKE CO19 citations92
US5549363AAug 27, 1996
Railway braking apparatus
WESTINGHOUSE AIR BRAKE CO23 citations92
USAA
3 patentsRADIN ALLEN
3 patentsUS8568721B2Oct 29, 2013
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN18 citations92
US8192741B2Jun 5, 2012
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
RADIN ALLEN22 citations92
US8080248B2Dec 20, 2011
Method of treating rheumatoid arthritis with an IL-6R antibody
RADIN ALLEN15 citations92
UNITED SERVICES AUTOMOBILE ASS (USAA)
2 patentsMICROSOFT CORP
2 patentsDAVIS SAMUEL
1 patentINFINITEKEY INC
1 patentIROBOT CORP
1 patentSPINDANCE INC
1 patentDENSO CORP
1 patentETHICON ENDO SURGERY INC
1 patentSMITH ERIC
1 patentSTEVENS SEAN
1 patentDEPUY SPINE INC
1 patentCIRRUS LOGIC INC
1 patentBORDEN INC
1 patentDEPUY ACROMED INC
1 patentDENSO INT AMERICA INC
1 patentVULCAN INC
1 patentBROOKS BENJAMIN
1 patentTOYOTA ENG & MFG NORTH AMERICA
1 patentShowing the top 50 of 187 patents by PatentIndex Score.